Additional research addressing the connection between chronic obstructive pulmonary disease (COPD) and metabolic syndrome is ...

Young teens might think smoking makes them look cool, but it’s likely to take their breath away in adulthood, a new st ...

Additional research addressing the connection between chronic obstructive pulmonary disease (COPD) and metabolic syndrome is ...

Study AER-01-002 is using a novel and precision imaging strategy to enroll 100 mucus plug-high chronic obstructive pulmonary disease (COPD) ...

Childhood smoking before age 15 increases a person's risk of developing chronic obstructive pulmonary disease (COPD), ...

For patients with COPD, budesonide-glycopyrrolate-formoterol does not improve clinical outcomes compared with fluticasone-umeclidinium-vilanterol.

A study reveals childhood smoking significantly increases COPD risk in adulthood, highlighting the need for targeted ...

Individuals with early-onset COPD and rapidly progressive pre-COPD frequently have a decades-long history of impaired ...

TRN-157 is under clinical development by Theron Pharmaceuticals and currently in Phase I for Chronic Obstructive Pulmonary Disease (COPD).

AZD-6793 is under clinical development by AstraZeneca and currently in Phase I for Chronic Obstructive Pulmonary Disease (COPD).